What we're reading, January 19, 2017: California has withdrawn a request to sell health coverage for illegal immigrants; Pfizer's CEO pushes back against Donald Trump's depiction of the pharmaceutical industry; some Republican governors urge caution on Obamacare repeal.
With Donald J. Trump’s administration poised to enter the White House, California has backed off a request to sell unsubsidized health insurance to illegal immigrants. According to AP, Covered California was notified that the request in to CMS would face a 1-month comment period and a 180-day window for the final decision, which would let the decision fall to Trump’s administration. Currently, immigrants who do not have legal status can buy health coverage through an insurance agent.
One pharmaceutical executive is pushing back against Trump’s depiction of the industry. At the World Economic Forum in Davos, Switzerland, Pfizer’s CEO said pharmaceutical companies are not, as Trump said, “getting away with murder,” according to FiercePharma. Ian Read said the reputation that the pharmaceutical industry has gotten does not represent the ethical part of the industry. He distanced himself from Martin Shkreli, the former CEO of Turing Pharma, as well as Valeant Pharmaceuticals.
Some Republican governors are urging that Republican lawmakers show caution as they work to repeal the Affordable Care Act. Governors who have expanded Medicaid are concerned about the effect of repealing the healthcare law, reported The Wall Street Journal. Ohio Governor John Kasich will join at least 8 other governors and 2 lieutenant governors for a roundtable, Senate Finance Committee Republicans, on the future of Medicaid expansion.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More